EC Number |
Expression |
Reference |
---|
1.10.3.11 | down |
auxin is a strong negative regulator of AtAOX1 a transcript abundance |
765865 |
1.10.3.11 | down |
the enzyme is suppressed by salicylhydroxamic acid at 200 and 400 mM NaCl, in negative correlation with malondialdehyde content |
765281 |
1.10.3.11 | down |
the transcription factor MYB29 acts as a negative regulator, not directly by binding the AtAOX1a promoter, but rather by crosstalk with a number of hormone signalling pathways that interact with ETHYLENE RESPONSE FACTOR and WRKY transcription factors |
765865 |
1.10.3.11 | down |
WRKY transcription factors 15 and 40 act as negative regulators of AtAOX1a. It is possible that they and other negative regulators are displaced when the latent NAC17 transcription factor is released from the ER upon proteolysis, with subsequent competition for the binding site |
765865 |
1.10.3.11 | up |
0.2 and 0.3 mM As(V) treatments enhance AOX1a expressions by 2.5- and 5.2folds as compared to control, respectively |
765552 |
1.10.3.11 | up |
0.2 or 0.3 mM As(V) treatment enhances AOX2 expression by 2- and 3.4fold as compared to control |
765552 |
1.10.3.11 | up |
0.3 mM As(V) treatment enhances AOX1d expression tenfold |
765552 |
1.10.3.11 | up |
AOX1b is induced by all As(V) treatments (0.1, 0.2 and 0.3 mM) |
765552 |
1.10.3.11 | up |
cyclin-dependent kinase E1 (CDKE1), a subunit of the mediator complex, is required for induction of AOX1a in Arabidopsis,acting at both a transcriptional and post-transcriptional level |
765865 |
1.10.3.11 | up |
cytochrome bd-I-deficient Escherichia coli strain cydB has elevated levels of the AppBC cytochrome bd-II terminal oxidase |
-, 715509 |